The size of the North America Pharmaceutical Membrane Filtration market is forecasted to worth USD 5.13 billion by 2027 from USD 2.87 billion in 2022, registering a CAGR of 12.3% from 2022 to 2027.
The growing adoption of single-use industries and advancements in Nanofiltration technologies are expected to drive the North American pharmaceutical membrane filtration market over the coming periods. Additionally, the increased number of drug launches and the increasing adoption of generic drugs will accelerate the robust growth of the North American pharmaceutical membrane filtration market in the years to come. Besides, the growing advancements in the production of large molecules and biologics are expected to impact the growth in the size of the North American pharmaceutical membrane filtration market over the anticipated period.
The increased incidence of viral and chronic diseases such as anthrax, measles, influenza, tuberculosis, and chickenpox has generated a demand for advanced drugs and vaccines. These factors will influence the growth of the North American membrane filtration pharmaceutical industry. Also, the increasing application of membrane filtration at many stages of drug production and development, ranging from production scale development to laboratory research, such as drug manufacture, disposal virus, detection Laboratory-scale drug testing, sample preparation, protein separation, and cell culture will witness the growth of the North American pharmaceutical membrane filtration market.
The strict guidelines governing pharmaceutical membrane filtration and the high cost associated with the technology are some of the major factors expected to limit the pharmaceutical membrane filtration market's growth. The cost of running membrane filters is very high, resulting in these filters' low cost, which creates a challenge for the market. Lack of proper knowledge over the use of membrane filters is restraining the demand of the market. Regular maintenance issues and complicated procedures such as membrane fouling are other challenges for market players, limiting the market growth.
This research report on the North America Pharmaceutical Membrane Filtration Market has been segmented and sub-segmented into the following categories:
By Product:
By Technique:
By Application:
By Country:
Regional Analysis:
North America accounts for the largest share in the global pharmaceutical membrane filtration market. Growth in North America is basically due to the increasing instances of airborne diseases, which result in higher production generic drug production.
The United States and Canada have well-structured and developing health systems. These countries also encourage pharmaceutical research and development and therefore have very high health costs. As a result of these policies, many companies worldwide are encouraged to operate in this region. Many global pharmaceutical players have their headquarters and research laboratories in the United States. This large portion can be attributed to the growing demand for biopharmaceuticals and the increased R&D spending of biopharmaceutical companies in North America.
Companies playing a dominant role in the North American Pharmaceutical Membrane Filtration Market profiled in this report are Merck KGaA (Germany), General Healthcare Company (U.K.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), GEA Group (Germany), and Novasep (U.S.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 MCE Membrane Filters
5.1.2 Coated Cellulose Acetate Membrane Filters
5.1.3 Nylon Membrane Filters
5.1.4 PTFE Membrane Filters
5.1.5 PVDF Membrane Filters
5.1.6 Other Membrane Filters
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Technique
5.2.1 Microfiltration
5.2.2 Ultrafiltration
5.2.3 Nanofiltration
5.2.4 Crossfiltration
5.2.5 Reverse Osmosis
5.2.6 Ion Exchange
5.2.7 Y-o-Y Growth Analysis, By Technique
5.2.8 Market Attractiveness Analysis, By Technique
5.2.9 Market Share Analysis, By Technique
5.3 Application
5.3.1 Final Product Processing
5.3.2 Raw Material Filtration
5.3.3 Cell Separation
5.3.4 Water Purification
5.3.5 Air Purification
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technique
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technique
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technique
6.1.5.4 By Application
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Novasep
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck KGaA (Germany)
8.3 GE Healthcare Company (U.K.)
8.4 Pall Corporation (U.S.)
8.5 Sartorius Stedim Biotech Group (France)
8.6 Alfa Laval (Sweden)
8.7 Graver Technologies
8.8 LLC (U.S.)
8.9 Koch Membrane Systems Inc. (U.S.)
8.10 GEA Group (Germany)
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
